Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?"
暂无分享，去创建一个
D. Samuel | C. Robert | O. Lambotte | C. Guettier | S. Champiat | A. Marabelle | J. Michot | E. De Martin | B. Papouin
[1] B. Somer,et al. Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer , 2018, JAMA oncology.
[2] C. Horak,et al. Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial. , 2016, The Lancet. Oncology.
[3] R. Kefford,et al. Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] D. Samuel,et al. Liver injury from cancer immunotherapy using monoclonal immune checkpoint inhibitors , 2018 .